Oportuzumab monatox (OM) is a recombinant fusion protein consisting of a humanized single variable chain fragment binding an epithelial cell adhesion molecule (EpCAM) fused to Pseudomonas exotoxin (ETA-252-608) [107]. This evidence concerns the gene EPCAM and ocular melanoma.